Article
Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
Archivum immunologiae et therapiae experimentalis - 1 Dec 2012
Lech-Maranda Ewa, Grzybowska-Izydorczyk Olga, Wyka Krystyna, Mlynarski Wojciech, Borowiec Maciej, Antosik Karolina, Cebula-Obrzut Barbara, Makuch-Lasica Hanna, Nowak Grazyna, Klimkiewicz-Wojciechowska Gabriela, Wawrzyniak Ewa, Bilinski Przemyslaw, Robak Tadeusz, Warzocha Krzysztof
Abstract excerpt
Tumor necrosis factor (TNF)-α and interleukin (IL)-10 are cytokines involved in the balance between cell-mediated and humoral immunity. We investigated whether serum TNF-α and IL-10 levels have any impact on clinical outcome of patients with chronic lymphocytic leukemia (CLL). TNF-α and IL-10 lev...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.